News
Elon Musk’s Neuralink is a last chance at a normal life for some
Kate Kegans doesn’t own a Tesla or any other products from Elon Musk’s many entities. Still, his Neuralink program could be her last chance at a normal life after experiencing vision impairments nearly nine years ago.
“I started having double vision, especially when I looked down,” Kegans said about her initial symptoms in 2011. “I went to my ophthalmologist. He goofed around with contact lenses for a year with no improvement, so my General Physician recommended a specialist.” An MRI revealed a cavernous malformation on her brain stem, which sent her to a Brain and Spine specialist in Phoenix, Arizona.
After having one resection of the malformation in 2011, the issues didn’t resurface for three years, until the doctor who performed the first surgery performed another one in 2015. However, the 2015 surgery didn’t go all the way to completion after “unfavorable conditions” aborted the effort once the surgery began.
Kate then underwent a third surgery to attempt the resection of the cavernous malformation in July 2018. While doctors called this surgery a success, Kegans has not lived a normal life since. After the surgery, she began experiencing symptoms that came to be recognized as signs of complete hemi-body dysesthesia, which included freezing and burning sensations on the right side of her body, and the inability to feel temperature changes on that side, making her prone to burns and scalds.
“Honestly, at this point, I wish I had not done the procedure, and dealt with the ‘ticking time bomb’ instead,” she said. As a result, Kegans has been forced to look at nearly every option due to relatively no improvement in her condition.
“I have tried extensive surgical procedures to ‘fix’ this,” she told Teslarati. Kegans then outlined the extensive list of treatments that have come to no resolve for her issues. Everything from Deep Brain Stimulation (the process of sending electrical impulses to specific targets in the brain), an Intrathecal Catheter with PRIALT (a pump placed in the body with a direct line that delivers medication into the spinal fluid), multiple cingulotomies (a surgery where tissue in the anterior cingulate region of the brain is altered, creating a lesion), Gamma Knife Radiation (surgery that destroys precisely selected areas of tissue by using radiation and not a blade), and a mesencephalotomy (an ablative procedure which lesions the pain pathways at the midbrain level to treat pain), all have had no effect on her condition.
In fact, one surgery disrupted her vision, an issue that was eventually fixed with another episode that took Kegans under the knife in November 2019. After it was fixed, the mesencephalotomy, which took place in July 2020, disrupted her vision once again. After having another surgery just eight weeks ago to improve her vision, she states that it still has not been fixed.
After trying a non-surgical route through various medications, including ketamine infusions, medicinal marijuana, gabapentin, and naltrexone, Kegans has one more option, as she says she is desperate. “I am willing to try anything to get back to normal.”
Enter: Neuralink
In August 2020, Elon Musk unveiled the “Link v0.9,” Neuralink’s latest and greatest implant device aimed to begin the surge toward curing various neurological diseases. A few sassy pigs with Neuralink chips implanted in their brains were among the first publicly unveiled test subjects. One, in particular, Gertrude, was a great example of how Neuralink could be used to battle various neurological diseases, including the loss of limb function.
Elon Musk’s Neuralink unveils sleek V0.9 device, uses sassy pigs for live brain machine demo
The Neuralink implant was able to predict all the limb movements based on the neural activity that was being read. With all of the improvements and developments in the Neuralink chip, many became believers in Musk’s most recent endeavor. One of them, a friend of Kegans, who sent her information about the pigs from the demonstration.
“My friend, who is a nurse, sent me an article on Neuralink. They said that human trials would eventually start,” Kegans said.
Neuralink has a handful of problems that it plans to solve on the neurological spectrum of injuries. Everything from memory loss, to blindness, to paralysis, to seizures will be a target for the chip. Another one is extreme pain, something that Kegans experiences on a daily basis, and it has affected her ability to live a normal life for years.
“I am 57 years old,” she said. “I used to be very active, and I need help returning to a normal life. I have zero quality of life now, and I am willing to try anything to get back to normal.”
FDA Designation, and what lies ahead for Neuralink’s possible patients
In July, the Food and Drug Administration (FDA) gave Neuralink a “breakthrough device” designation, allowing the company to continue working with its Link v0.9. Eventually, the device could be sewn deeper into the brain, allowing for a wider variety of functions beyond the upper cortex. Some of the issues that could be solved would deal with addiction, depression, and motor function.
As of now, human trials are the next step for Neuralink to make some real noise in the medical sector. On February 1st, Musk gave an update regarding Neuralink’s development with the FDA, where he indicated the company was in constant communication with the federal agency to ensure implant safety.
Neuralink is working super hard to ensure implant safety & is in close communication with the FDA. If things go well, we might be able to do initial human trials later this year.
— Elon Musk (@elonmusk) February 1, 2021
After stating that human trials could begin as soon as this year, several people, Kegans included, reached out to talk about the possibility of being included in the first Neuralink trials. While no details are known yet, there are plenty of people out there who have been affected by severe brain injuries that have negatively altered their lives. Neuralink could be the key to eventually making neurological disorders a thing of the past, especially as the company plans to create a chip that will be affordable for virtually everyone.
A Tesla Cybertruck driver in the United Kingdom had their all-electric pickup seized by local police in the Greater Manchester area after the department cited “legitimate concerns.”
Last Thursday, police saw the pickup on the roads and decided to pull the driver over. Greater Manchester Police said:
“Whilst this may seem trivial to some, legitimate concerns exist around the safety of other road users or pedestrians if they were involved in a collision with the Cybertruck.”
🚨 A Tesla Cybertruck, which is illegal to drive in the UK due to safety concerns, has been seized by police in Greater Manchester
“Whilst this may seem trivial to some, legitimate concerns exist around the safety of other road users or pedestrians if they were involved in a… pic.twitter.com/cqhdPok3DM
— TESLARATI (@Teslarati) June 16, 2026
The Cybertruck in question was, according to the BBC, registered and insured abroad and was confiscated. The driver, who is a UK resident, was reported.
The Greater Manchester Police Department then added:
“The Tesla Cybertruck is not road-legal in the UK and does not hold a certificate of conformity.”
The Cybertruck cannot be legally driven in the UK because it has no UK Type Approval for operation in the country. This is due to some safety concerns, which are related to its angular shape and design. The stainless steel exoskeleton has sharp edges and projections that violate UK/EU rules on pedestrian protection.
Tesla has considered creating what it referred to as an “international version” that would be approved for operation in Europe. However, there has been no real movement on that front by the company, as it has been focused on the Robotaxi rollout primarily.
A new report claims that Apple is in the process of developing what would be the missing link for Tesla to get CarPlay.
Apple and Tesla have been reportedly working together for some time to give Tesla owners the opportunity to utilize CarPlay within their vehicles. While many owners are more than happy with Tesla’s in-house UI, which is seamless, effective, and smooth, some still want CarPlay, which does have its advantages.
A report from 9to5Mac now states that a new CarPlay technology that was highlighted during the Worldwide Developers Conference (WWDC) would potentially be the bridge between Tesla and Apple. With the addition of a feature known as “Route Sharing,” which gives a navigation app the ability to share routing data with the vehicle, Tesla would be able to launch CarPlay in its vehicles, the report states.
CarPlay has not been a priority for Tesla because it has done extremely well with its in-house UI, but some drivers are just used to it. Additionally, it could improve Tesla’s subpar Navigation or offer improved app capabilities, especially with iMessage.
Route Sharing is an intended addition to CarPlay’s iteration in iOS 26.4, which was released in March:
The addition of CarPlay would undoubtedly be welcome, but at the same time, it seems like Tesla realizes it is not of the utmost priority. There are so many things that Tesla is working on currently within its own vehicles, especially attempting to solve self-driving.
Back in February, Bloomberg had reported that Tesla was still working on bringing CarPlay to its vehicles, but it had not due to app compatibility issues and incredibly low adoption rates of iOS 26.
This bottleneck could buy Tesla the proper amount of time to develop CarPlay for its vehicles. It would be a welcome addition, and could be brought on with either the Summer or Fall 2026 Software Updates.
Tesla deliveries got a big boost in expectations from Wall Street firm Goldman Sachs, who believes the company will report some stronger-than-expected numbers when the second quarter comes to an end in the coming weeks.
Goldman Sachs has raised its vehicle delivery forecast for Tesla (NASDAQ: TSLA) in the second quarter of 2026, signaling growing confidence in the electric vehicle leader’s near-term momentum despite mixed market signals. Analyst Mark Delaney lifted the bank’s Q2 estimate to 420,000 units from a previous 405,000, surpassing the Visible Alpha consensus estimate of 400,000.
The upward revision stems from stronger-than-expected sales data across key regions. Europe stands out with projected year-over-year growth of 85-90 percent, driven by robust demand for Tesla’s Model Y and refreshed offerings. China posted high single-digit gains, while markets like South Korea and Australia also contributed positive momentum. These gains help offset mid-teens declines in U.S. deliveries through May, where broader EV market headwinds and competition persist.
Goldman extended its optimism to the full year, increasing its 2026 delivery projection to 1.73 million vehicles from 1.72 million. Longer-term forecasts remain unchanged, with 1.88 million units expected in 2027 and 1.96 million in 2028. The bank also nudged its 2026 earnings-per-share estimate higher to $1.35 from $1.30, reflecting anticipated margin benefits from higher volumes and operational efficiencies.
Despite these positive adjustments, Goldman maintained its Neutral rating and $375 price target on Tesla shares. At current trading levels near $411, the stock sits about 8-9 percent above the target, highlighting ongoing valuation concerns even as delivery momentum builds. Tesla’s Q1 2026 deliveries totaled 358,023 units, setting a baseline for recovery expectations in the current period.
This update arrives as Tesla prepares to report official Q2 figures shortly after June 30. Investors and analysts will closely watch not only headline delivery numbers but also regional breakdowns, average selling prices, and progress on energy storage deployments and autonomous technology initiatives.
The move by Goldman Sachs underscores a broader narrative for Tesla: while legacy auto markets face softening demand and tariff uncertainties, Tesla’s global footprint and product pipeline provide resilience. Europe’s surge reflects pent-up demand and policy support for EVs, while China’s steady growth highlights Tesla’s competitive positioning against local rivals.
Tesla still has its work cut out for it, including U.S. price sensitivity and intensifying competition. Yet Goldman’s revision adds to a series of analyst notes suggesting Q2 could mark a turning point. As Tesla pushes toward higher production rates at facilities in Fremont, Shanghai, and Berlin, sustained execution will be key to validating these higher forecasts.
We have said numerous times that deliveries are becoming a less important metric in the grand scheme of things, as AI truly takes precedence in the company’s thesis.
For Tesla bulls, the Goldman note reinforces faith in underlying demand trends. For skeptics, the unchanged rating serves as a reminder that delivery beats alone may not immediately resolve valuation debates in a high-interest-rate environment. Tesla’s stock reaction will likely hinge on the official numbers and management commentary in the coming weeks.
Tesla Cybertruck driver gets pickup seized for ‘legitimate concerns’ in UK
Apple is developing the missing link for Tesla to get CarPlay: report
